Divi's Labs is a sure-shot pill to profit

The scrip is at Rs 774 with a price and volume break-out today.
It is resting on 20D EMA and with NIFTY's assistance in coming weeks, may gallop to close the huge fall experienced earlier from Rs 1100 levels mainly due to US FDA inspection and recommendations.
The company has completed the recommendations satisfactorily and is waiting for market fancy .
Technically and fundamentally, it is underpriced. Book Value is a healthy Rs 195, PE=18, a debt-free balance sheet , growing turnover and profits, it should return to its previous glory pretty soon.


Thanks for your wonderful analysis!

Agree with your views - I have a lot of Divi's Lab shares in my portfolio - I also believe it is fundamentally very sound and shown consistent profit and growth in all segments over the years and presents a very good opportunity to buy currently.
+1 Reply
Thanks for your views, I am adding it right away to my portfolio !
Home Stock Screener Forex Screener Crypto Screener Economic Calendar About Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter
Profile Profile Settings Account and Billing Referred friends Coins My Support Tickets Help Center Private Messages Chat Sign Out